| Title |
The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction
|
|---|---|
| Published in |
Cardiovascular Drugs and Therapy, January 2001
|
| DOI | 10.1023/a:1011119003788 |
| Pubmed ID | |
| Authors |
Bertram Pitt, Gordon Williams, Willem Remme, Felipe Martinez, Jose Lopez-Sendon, Faiez Zannad, James Neaton, Barbara Roniker, Steve Hurley, Dan Burns, Richard Bittman, Jay Kleiman |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 3% |
| Chile | 1 | <1% |
| Italy | 1 | <1% |
| Egypt | 1 | <1% |
| Denmark | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 93 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 20% |
| Other | 11 | 11% |
| Student > Bachelor | 9 | 9% |
| Student > Doctoral Student | 8 | 8% |
| Professor | 8 | 8% |
| Other | 24 | 24% |
| Unknown | 21 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 53% |
| Agricultural and Biological Sciences | 8 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Engineering | 2 | 2% |
| Other | 3 | 3% |
| Unknown | 28 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2021.
All research outputs
#2,655,912
of 25,374,647 outputs
Outputs from Cardiovascular Drugs and Therapy
#46
of 766 outputs
Outputs of similar age
#4,099
of 114,352 outputs
Outputs of similar age from Cardiovascular Drugs and Therapy
#1
of 3 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 766 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 114,352 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them